Table 3 Adjusted mean differences from fitting an ANCOVA model (contrasts between groups)
From: Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
Unadjusted and adjusted mean difference at T1 (log2 scale) | ||||
|---|---|---|---|---|
Unadjusted Mean (95% CI) | p-value | Adjusted* mean (95% CI) | p-value | |
RBD-binding IgG | ||||
HCDR | 0 | 0 | ||
ICDR | 0.66 (0.09, 1.24) | 0.025 | 0.50 (−0.08, 1.08) | 0.093 |
PCDR | 1.09 (0.38, 1.80) | 0.003 | 0.05 (−0.84, 0.94) | 0.910 |
nAb titres | ||||
HCDR | 0 | 0 | ||
ICDR | 0.51 (−0.16, 1.17) | 0.136 | 0.27 (−0.47, 1.01) | 0.478 |
PCDR | 0.13 (−0.69, 0.95) | 0.755 | −0.70 (−1.84, 0.45) | 0.234 |
IFN-γ | ||||
HCDR | 0 | 0 | ||
ICDR | −0.43 (−1.36, 0.49) | 0.358 | −0.03 (−1.15, 1.10) | 0.962 |
PCDR | −0.43 (−1.59, 0.73) | 0.470 | −0.43 (−2.18, 1.31) | 0.628 |
